Another cretinous comment. So developments with regulatory authorities approval processes, for the treatment pathways, of bio-techs planning to lodge applications with said regulatory authorities, are off topic. Right. How about clearances or progress with regulatory bodies? Are they allowed?
You really do waste everyone's time. Its a not unimportant peace of news effecting any Australian bio-tech company with, or planning, applications with the FDA you ignoramus.
RCE Price at posting:
31.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)